Product
Copaxone
2 clinical trials
7 indications
Indication
acute decompensated heart failureIndication
Cytokine StormIndication
Inflammatory ResponseIndication
Congestive Heart FailureIndication
Cutaneous Squamous Cell CarcinomaIndication
Squamous Cell CarcinomaIndication
Basal Cell CarcinomaClinical trial
Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart FailureStatus: Completed, Estimated PCD: 2023-03-12
Clinical trial
A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible TumorsStatus: Active (not recruiting), Estimated PCD: 2022-12-07